MTOR and cancer: We found that higher SRC expression is significantly associated with activated RTK (receptor tyrosine kinase; 16%) and TSC/mTOR (tuberous sclerosis complex/mechanistic target of rapamycin; 12%) pathways in pan-cancer, indicating its potential role in promoting cell growth and survival.